Nonclinical collaboration request (funding and/or materials) supports academic investigators with Amgen funding, proprietary molecules, or related materials to carry out nonclinical scientific research.
Funder: Amgen
Due Dates: Preliminary discussion required before submission
Funding Amounts: Funding, materials, or both
Summary: Supports nonclinical collaborative research through requests for Amgen funding, materials, or both.
Key Information: Applicants must discuss their proposal with an Amgen Global Medical Organization representative before submitting.
Amgen accepts nonclinical collaboration requests seeking funding, materials, or a combination of both. Its nonclinical submission page directs applicants to the Academic Collaborations program, through which Amgen supports extramural research at academic institutions by providing non-commercialized proprietary molecules and related materials for scientific research.
Academic investigators requesting materials provide a description of their study plan for consideration by an Amgen scientific review team. The materials program is for non-human studies, not human or clinical use. Approved requests proceed to an agreement between Amgen and the investigator’s institution, covering use of the materials, access to research results, reporting, inventions, and review before public disclosure.